AA
PKBOW

AQR Arbitrage’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

AQR Arbitrage’s Portfolio PKBOW Stock Details PKBOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-25,000
Closed -$3K – 1299
2022
Q3 		$3K Hold
25,000
– – ﹤0.01% 1329
2022
Q2 		$5K Hold
25,000
– – ﹤0.01% 1367
2022
Q1 		$9K Hold
25,000
– – ﹤0.01% 1277
2021
Q4 		$244K Buy
+25,000
New +$18.3K 0.01% 1077

Other funds holding PKBOW

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

AQR Arbitrage's PKBOW Position: Q4 2022 in Review

AQR Arbitrage sold out of Peak Bio, Inc. Warrant (PKBOW) in Q4 2022, closing a stake of 25,000 shares — an estimated $3K sold.

AQR Arbitrage first reported a position in PKBOW in Q4 2021 and held it in 4 quarters. The position peaked at $244K in Q4 2021. 15 funds tracked by Wall St. Rank hold PKBOW as of Q4 2022.

  • AQR Arbitrage reported no remaining Peak Bio, Inc. Warrant position as of Q4 2022 after selling out during the quarter.
  • AQR Arbitrage sold 25,000 Peak Bio, Inc. Warrant shares in Q4 2022, an estimated $3K.
  • AQR Arbitrage first reported a position in Peak Bio, Inc. Warrant in Q4 2021 and held it in 4 quarters.
  • AQR Arbitrage's Peak Bio, Inc. Warrant position peaked at $244K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q4 2022.

Based on AQR Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.